Montego-CV 162.5 mg DT
Composition : Cefpodoxime 100 mg & Potassium Clavulanate 62.5 mg Dispersible Tablets
Read MoreTherapeutic Segment : Antibiotic | Anti-Infective
Packing : 1 x 10 (Alu-Alu)
Dosage : 1 Tablet twice daily for 5-14 days
Product Information
Cefpodoxime 100 mg & Potassium Clavulanate 62.5 mg dispersible tablets are a combination antibiotic used to treat diverse bacterial infections, including respiratory, ENT (ear, nose, throat), skin, and urinary tract infections. The formula combines Cefpodoxime (a third-generation cephalosporin) to kill bacteria with Potassium Clavulanate (a beta-lactamase inhibitor) to prevent antibiotic resistance.
- Acute Bacterial Sinusitis
- Recurrent Pharyngitis & Tonsillitis
- Skin & Soft Tissue Infections
- Community Acquired Pneumonia
- Hospital acquired Pneumonia
- AECB
- Typhoid Fever
- Acute Otitis Media
- Bone & Joint Infections
- Urogenital Infections
- Take this medicine in the dose and duration as advised by your doctor.
- Swallow it as a whole.
- Do not chew, crush or break it.
Cefpodoxime Proxetil + Clavulanic Acid is a combination of two medicines: Cefpodoxime Proxetil and Clavulanic Acid. Cefpodoxime Proxetil is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria. Clavulanic Acid is a beta-lactamase inhibitor which reduces resistance and enhances the activity of Cefpodoxime Proxetil against bacteria.
Montego 100 mg Dry Syrup | Montego 100 mg DT
Montego 200 mg DT | Montego 50 mg Dry Syrup
Montego 50 mg DT | Montego Drops
Montego-CV 100 mg Dry Syrup | Montego-CV 162.5 mg DT
Montego-CV 325 mg Tablets | Montego-CV 50 mg Dry Syrup | Montego-O Tablets
